UCB Pharma AB (Sweden)
Olof Palmes gata 29
SE-111 22 Stockholm
Telephone: +46 (0)40-294900

Companies with similar products and services, and with detailed information

Products and services

To view this data requires an Access
Fiscal year 202312
Number of months: 12
Turnover: 233,450
Financial expenses: 705
Earnings before taxes: 12,192
Total assets: 168,065
Current assets: 168,065
Current liabilities: 104,625
Equity capital: 63,440
Share capital: 100
Number of employees: 35

Financial ratios

Solvency: 37.7%
Turnover per employee: 6,670
Profitability: 5.2%
Return on equity (ROE): 19.2%
Current ratio: 160.6%
Return on assets (ROA): 7.7%